SynthesisAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2026
Cimlanod, a Second-Generation Nitroxyl Donor, in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis of Hemodynamic Efficacy and Safety Profile.
Mrunalini Dandamudi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.